Please login to the form below
Actavis to buy Warner Chilcott in $8.5bn deal
Combined company will have annual revenues of about $11bn
Healthcare at Home and QED partner on orphan diseases
OrphanReach alliance will see companies provide product lifecycle services
France ignores EMA and suspends Bayer's Diane 35
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
New vortioxetine studies reinforce efficacy in depression
Supports marketing applications from Takeda and Lundbeck
India puts cost controls on medicines
Drugs (Prices Control) Order 2013 reduces price of hundreds of drugs
Sanofi reconsiders closure plans in Toulouse after government pressure
Report says research site can remain open with minimal job losses
EMA says Bayer's Diane 35 should remain on European market
Agency investigation concludes acne treatment's benefits outweigh its risks
PMEA 2013 opens for entry
Programme recognises responsible marketing and business practice in the healthcare industry
J&J's Simponi wins FDA approval in ulcerative colitis
Adds to rheumatoid arthritis, psoriatic arthritis and active ankylosing spondylitis indications in the US
Chasing the cure for Parkinson’s disease
Research for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
-
From paralysis to analysis: the journey to multichannel marketingTo make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
-
Bringing trial data out of the shadowsTransparency of clinical trial data has become a hotly disputed topic recently, how the industry at large will respond is still not clear, but as the noise grows louder, reputations
-
Sanofi plans to file JAK2 inhibitor after positive phase IIIAiming for approval in blood cancer myelofibrosis
-
Bayer boosts consumer care business with Steigerwald purchaseFuels ambition to become world leader in OTC medicines
-
NICE recommends Astellas' Betmiga for overactive bladderFinal draft guidance recommends Vesicare successor
-
Amgen and Novartis partner with biotech venture capital firm
Atlas Venture fund aims to create 15 new biotech companies
-
Merck KGaA forges clinical alliance with QuintilesCRO becomes sole outsourcing partner for pharma company
-
FDA clears Bayer/ Algeta's prostate cancer radiotherapy
Approval for Xofigo comes three months ahead of schedule
-
Video for neglected tropical diseases challenges viewersNon-profit organisation END7 asks: 'Can you watch what they watched?'
Latest appointments
-
Boehringer's Wolfram Carius to step downHe will be replaced by Wolfgang Baiker on the board of managing directors
-
Canada role for UCB's Hervé Lilliu Appointed general manager of biopharma company’s operations in the country
-
Former NICE chair joins board of biotechSir Michael Rawlins joins board of Intra-Cellular Therapeutics
-
Lundbeck's Steve Turley re-elected as EMG chairAnd Actelion's Robin Bhattacherjee retains vice-chair position
-
VC firm expands team, appoints Genzyme and Lilly veteransNew roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Boehringer Ingelheim and Lilly launch diabetes education campaign
- GSK to set up online system for trial data requests
- Former Google chief launches online cancer forum
- Global biosimilars market to reach $2.45bn in 2013
- Value-based pricing "not in patient interest"
PMHub
Add my companyOgilvy Healthworld
'We have a habit of divine discontent with our performance.It is an antidote to smugness.'So said David Ogilvy. ...
Latest intelligence
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
- A guide to developing customer-centred, multichannel marketing
- Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in ...
Quick links
